DeepSyte™
Bill FeedAll repsScoreboardsPrimariesProAboutSign inGet started
DeepSyte™™

A nonpartisan civic accountability tool. We match federal legislation to your stated values — without partisan bias.

Learn

  • About
  • About the name
  • Methodology
  • Glossary

Legal

  • Privacy
  • Terms of Service
  • Refund Policy
  • Contact

Sources

Bill data from Congress.gov. Summaries from the Congressional Research Service where available.

Follow

  • Bluesky — @deepsyte.app
  • X — @deepsyteapp
All content is for informational purposes only. Always verify against primary sources.
Back to bill feed
119-hr-6609Committee
Sign in to get alerts

Pharmacists Fight Back in Medicare and Medicaid Act

Read the record. Not the rhetoric.

See how your representatives voted on this bill.

DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.

Get started freeTake the values quiz

Alignment with your views

Sign in and take the values quiz to see how this bill lines up with what you've said.

Summary

AI-generated summary — verify against full text

This bill amends Medicare and Medicaid law to establish requirements for pharmacy benefit managers (PBMs) and prescription drug plans regarding drug reimbursement, rebate pass-through, and pharmacy steering. Starting in 2027, PBMs must reimburse in-network pharmacies based on national average drug acquisition cost plus a markup, pay state-level dispensing fees without passing costs to patients, and pass manufacturer rebates through to patients at the point of sale. The bill prohibits PBMs from steering patients to affiliated pharmacies and requires annual compliance reporting.

Read full bill text

Values analysis

Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.

Bill details

Congress
119
Bill type
hr
Introduced
December 11, 2025
Sponsor
Jake AuchinclossDMA
Cosponsors
40
Last action
December 11, 2025— Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

How your representatives voted

Sign in to see how your representatives voted on this bill.